Cardiovascular and Functional Effects of Testosterone Therapy for Hypogonadal Patients With Heart Failure

Trial Profile

Cardiovascular and Functional Effects of Testosterone Therapy for Hypogonadal Patients With Heart Failure

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 21 Jul 2017

At a glance

  • Drugs Testosterone (Primary)
  • Indications Heart failure; Hypogonadism
  • Focus Adverse reactions; Biomarker; Therapeutic Use
  • Most Recent Events

    • 14 Jul 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
    • 07 Jul 2011 Planned initiation date changed from 1 Jun 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.
    • 24 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top